Cargando…

SPTBN2, a New Biomarker of Lung Adenocarcinoma

OBJECTIVES: The roles played by β-III-spectrin, also known as spectrin beta, non-erythrocytic 2 (SPTBN2), in the occurrence and development of lung adenocarcinoma (LUAD) have not been previously examined. Our study aimed to reveal the relationship between the SPTBN2 expression and LUAD. MATERIALS AN...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Chunli, Dong, Bo, Huang, Lan, Liu, Yafei, Ye, Guanchao, Li, Shihao, Qi, Yu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8563792/ https://www.ncbi.nlm.nih.gov/pubmed/34745988 http://dx.doi.org/10.3389/fonc.2021.754290

Ejemplares similares

miRNA-218/FANCI is associated with metastasis and poor prognosis in lung adenocarcinoma: a bioinformatics analysis
por: Ye, Guanchao, et al.
Publicado: (2021)

Single-cell transcriptome analysis demonstrates inter-patient and intra-tumor heterogeneity in primary and metastatic lung adenocarcinoma
por: Liu, Yafei, et al.
Publicado: (2020)

Macrophage-Related SPP1 as a Potential Biomarker for Early Lymph Node Metastasis in Lung Adenocarcinoma
por: Dong, Bo, et al.
Publicado: (2021)

Correlation of m6A methylation with immune infiltrates and poor prognosis in non-small cell lung cancer via a comprehensive analysis of RNA expression profiles
por: Dong, Bo, et al.
Publicado: (2021)

A pan-cancer analysis of the oncogenic role of secreted phosphoprotein 1 (SPP1) in human cancers
por: Liu, Yafei, et al.
Publicado: (2022)

m7G-related gene NUDT4 as a novel biomarker promoting cancer cell proliferation in lung adenocarcinoma
por: Liu, Yafei, et al.
Publicado: (2023)

Screening microRNAs as potential prognostic biomarkers for lung adenocarcinoma
por: Dai, Hongshuang, et al.
Publicado: (2023)

Carboxypeptidase N2 as a Novel Diagnostic and Prognostic Biomarker for Lung Adenocarcinoma
por: Xu, Ting, et al.
Publicado: (2022)

Fucosylated exosomal miRNAs as promising biomarkers for the diagnosis of early lung adenocarcinoma
por: Chen, Xiongfeng, et al.
Publicado: (2022)

Immune microenvironment analysis and novel biomarkers of early-stage lung adenocarcinoma evolution
por: Liu, Jun, et al.
Publicado: (2023)

Lung adenocarcinoma harboring concomitant SPTBN1-ALK fusion, c-Met overexpression, and HER-2 amplification with inherent resistance to crizotinib, chemotherapy, and radiotherapy
por: Gu, Fei-fei, et al.
Publicado: (2016)

Identification of VWF as a Novel Biomarker in Lung Adenocarcinoma by Comprehensive Analysis
por: He, Yi, et al.
Publicado: (2021)

DNA Methylation in LIME1 and SPTBN2 Genes Is Associated with Attention Deficit in Children
por: Li, Sung-Chou, et al.
Publicado: (2021)

Downregulated Expression of CLEC9A as Novel Biomarkers for Lung Adenocarcinoma
por: Miao, Fang, et al.
Publicado: (2021)

CSF2RB Is a Unique Biomarker and Correlated With Immune Infiltrates in Lung Adenocarcinoma
por: Zhu, Ningning, et al.
Publicado: (2022)

A Diagnostic Panel of DNA Methylation Biomarkers for Lung Adenocarcinoma
por: Shen, Nan, et al.
Publicado: (2019)

Identifying and Validating Potential Biomarkers of Early Stage Lung Adenocarcinoma Diagnosis and Prognosis
por: Chen, Yingji, et al.
Publicado: (2021)

Prognostic Value of Inflammatory Biomarkers in Patients With Stage I Lung Adenocarcinoma Treated With Surgical Dissection
por: Shen, Yu-Jia, et al.
Publicado: (2021)

SPTBN2 Promotes the Progression of Thyroid Cancer by Accelerating G1/S Transition and Inhibiting Apoptosis
por: Zhou, Xiaofen, et al.
Publicado: (2022)

Pathogenic SPTBN1 variants cause an autosomal dominant neurodevelopmental syndrome
por: Cousin, Margot A., et al.
Publicado: (2021)

GPI Is a Prognostic Biomarker and Correlates With Immune Infiltrates in Lung Adenocarcinoma
por: Han, Jiahui, et al.
Publicado: (2021)

CDC25C as a Predictive Biomarker for Immune Checkpoint Inhibitors in Patients With Lung Adenocarcinoma
por: Zhang, Wengang, et al.
Publicado: (2022)

Integrated Analysis of Cell Cycle–Related and Immunity-Related Biomarker Signatures to Improve the Prognosis Prediction of Lung Adenocarcinoma
por: Chen, Fangyu, et al.
Publicado: (2021)

A Nomogram Combined Radiomics and Clinical Features as Imaging Biomarkers for Prediction of Visceral Pleural Invasion in Lung Adenocarcinoma
por: Zha, Xinyi, et al.
Publicado: (2022)

Identification of Key Genes Related to CD8+ T-Cell Infiltration as Prognostic Biomarkers for Lung Adenocarcinoma
por: Du, Minjun, et al.
Publicado: (2021)

Comprehensive analysis to identify a novel PTEN-associated ceRNA regulatory network as a prognostic biomarker for lung adenocarcinoma
por: Xin, Rui, et al.
Publicado: (2022)

Long Non-Coding RNA AL139385.1 as a Novel Prognostic Biomarker in Lung Adenocarcinoma
por: Chen, Xi, et al.
Publicado: (2022)

Prognostic value and immune infiltration of the gasdermin family in lung adenocarcinoma
por: Peng, Lu-Shan, et al.
Publicado: (2022)

Development and External Validation of a Nomogram for Predicting Cancer-Specific Survival of Non-Small Cell Lung Cancer Patients With Ipsilateral Pleural Dissemination
por: Wang, Zhenfan, et al.
Publicado: (2021)

CDCA4 as a novel molecular biomarker of poor prognosis in patients with lung adenocarcinoma
por: Tan, Jianlong, et al.
Publicado: (2022)

Revealing the Organ-Specific Expression of SPTBN1 using Single-Cell RNA Sequencing Analysis
por: Jung, Jongyun, et al.
Publicado: (2023)

SPTBN1 Prevents Primary Osteoporosis by Modulating Osteoblasts Proliferation and Differentiation and Blood Vessels Formation in Bone
por: Xu, Xuejuan, et al.
Publicado: (2021)

Circulating Long Noncoding RNAs Act as Diagnostic Biomarkers in Non-Small Cell Lung Cancer
por: Yuan, Shuai, et al.
Publicado: (2020)

Mutant-Allele Tumor Heterogeneity, a Favorable Biomarker to Assess Intra-Tumor Heterogeneity, in Advanced Lung Adenocarcinoma
por: Wu, Xiaoxuan, et al.
Publicado: (2022)

MARCH1 as a novel immune-related prognostic biomarker that shapes an inflamed tumor microenvironment in lung adenocarcinoma
por: Xu, Zhiyong, et al.
Publicado: (2022)

Pan-Cancer Integrated Analysis Identification of SASH3, a Potential Biomarker That Inhibits Lung Adenocarcinoma Progression
por: Chen, Xi, et al.
Publicado: (2022)

WDHD1 Leads to Cisplatin Resistance by Promoting MAPRE2 Ubiquitination in Lung Adenocarcinoma
por: Gong, Lian, et al.
Publicado: (2020)

Identification of Spindle and Kinetochore-Associated Family Genes as Therapeutic Targets and Prognostic Biomarkers in Pancreas Ductal Adenocarcinoma Microenvironment
por: Liu, Yi, et al.
Publicado: (2020)

AUNIP Expression Is Correlated With Immune Infiltration and Is a Candidate Diagnostic and Prognostic Biomarker for Hepatocellular Carcinoma and Lung Adenocarcinoma
por: Ma, Chenxi, et al.
Publicado: (2020)

βII spectrin (SPTBN1): biological function and clinical potential in cancer and other diseases
por: Yang, Panyu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5peua5c77s8cd9ieohh9e8arjn